Daniel J. O'Connor Seelos Therapeutics, Inc. (SEEL) insider trading activity

SEEL Quotes by TradingView

Daniel J. O'Connor is Director of SEELOS THERAPEUTICS, INC.. Currently has a direct ownership of 16,000 shares of SEEL, which is worth approximately $6,080. The most recent transaction as insider was on Jun 01, 2022, when has been sold 16,000 shares (Common Stock) at a price of $0.61 per share, resulting in proceeds of $9,760. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16K
0% 3M change
0% 12M change
Total Value Held $6,080

Daniel J. O'Connor Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2022
BUY
Open market or private purchase
$9,760 $0.61 p/Share
16,000 Added 50.0%
16,000 Common Stock

Also insider at

AMAM
Ambrx Biopharma Inc. Healthcare
President and CEO
ONCS
ONCOSEC MEDICAL Inc Healthcare
CEO and President
LSPR
Larkspur Health Acquisition Corp. Financial Services
Director
AMAM
Ambrx Biopharma, Inc.
President and CEO
DJO

Daniel J. O'Connor

Director
Pennington, NJ

Track Institutional and Insider Activities on SEEL

Follow SEELOS THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SEEL shares.

Notify only if

Insider Trading

Get notified when an Seelos Therapeutics, Inc. insider buys or sells SEEL shares.

Notify only if

News

Receive news related to SEELOS THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SEEL